Armistice Capital, LLC and Steven Boyd report a shared beneficial interest in Wearable Devices Ltd. Together they hold 54,042 ordinary shares, representing 4.99% of the class. Armistice Capital, as investment manager to a Master Fund, exercises voting and investment power over those shares and Mr. Boyd, as managing member, may be deemed to beneficially own them. The filings state the reported shares are held with shared voting and dispositive power (no sole voting or dispositive power). The Master Fund is identified as the direct holder and retains the economic right to dividends or sale proceeds.
Wearable Devices Ltd., an Israel-incorporated company, filed a Form D to register a warrant-based offering under Rule 506(b). The stated total offering amount is $2,408,450 with $0 reported sold to date and $2,408,450 remaining. The filing lists a first sale date of 2025-08-06 and indicates the offering is not intended to last more than one year.
The filing clarifies that gross proceeds reflect the cash exercise of 1,661,000 existing warrants in a warrant inducement transaction and that a concurrent private placement issued 3,322,000 new warrants. Proceeds up to $5,680,620 from new warrant exercises are excluded from the offering amount. Minimum investment is reported as $0, sales commissions and finders' fees are $0, and the notice reports one investor so far. The issuer identified its industry as Other Technology, declined to disclose revenue/net asset ranges, and the Form D was signed by CEO Asher Dahan on 2025-08-14.
Wearable Devices Ltd. submitted a Form 6-K to furnish a press release dated August 11, 2025, announcing that it has secured a U.S. patent for what it describes as groundbreaking neural interface technology. This report mainly serves to officially provide that press release to investors and regulators.
The company also states that selected paragraphs and the forward-looking statements section of the press release are incorporated by reference into its existing registration statements on Form S-8 and Form F-3, meaning those registration documents now legally include the updated patent-related disclosure.